NCT05544136 A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT05542706 Benefit of Paramedical Care in Accompanying Caregivers of Patients That Had Surgery for an Head and Neck Invasive Cancer Status RECRUITING Phase NA
NCT05540899 Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05539144 A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer Status COMPLETED Phase NA
NCT05538533 Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05535023 Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT05526924 Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer Status RECRUITING Phase PHASE1
NCT05526040 Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment Study Status UNKNOWN Phase NA
NCT05524454 Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy Status COMPLETED Phase NA
NCT05517330 Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT05500508 Oral AMXT 1501 Dicaprate in Combination With IV DFMO Status TERMINATED Phase PHASE1/PHASE2
NCT05490875 Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy Status COMPLETED Phase N/A
NCT05483374 The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers Status RECRUITING Phase N/A
NCT05477992 Haemorrhage Risk Reduction Using Endovascular Embolisation in Place of Vessel Ligation for Patients Undergoing Transoral Robotic Surgery (HELPR) Status UNKNOWN Phase NA
NCT05472506 Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer Status WITHDRAWN Phase PHASE1
NCT05442957 Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT Status RECRUITING Phase NA
NCT05429866 Immunological Variables Associated to ICI Toxicity in Cancer Patients Status UNKNOWN Phase PHASE2
NCT05427214 Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy Status COMPLETED Phase NA